• 1
    Munoz N,Bosch FX,de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348: 518527.
  • 2
    Markowitz LE,Dunne EF,Saraiya M,Lawson HW; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56(RR-2): 124.
  • 3
    Zeig-Owens R,Knowlton R,Gershman ST,Howe HL. CINA Highlights of Cancer Incidence and Mortality in the United States and Canada, 2000-2004. Springfield, IL: North American Association of Central Cancer Registries; 2007.
  • 4
    U.S. Cancer Statistics Working Group. United States Cancer Statistics: 2004 Incidence and Mortality. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2007.
  • 5
    North American Association of Central Cancer Registries. Working Group on Pre-Invasive Cervical Neoplasia and Population-Based Cancer Registries: Final Subcommittee Report. ([N]AACCR Conference held April 5-6, 1993, Rockville, MD. Adopted by the [N]AACCR Executive Board May 1993 and amended November 1993.)
  • 6
    HofferkampJ,HavenerL, eds. Standards for Cancer Registries. Volume II: Data Standards and Data Dictionary.12th ed. Version 11.2. Springfield, IL: North American Association of Central Cancer Registries; 2007.
  • 7
    Cancer. ACoSCo. Facility Oncology Registry Data Standards: Revised for 2007 (FORDS). Chicago: American College of Surgeons Commission on Cancer; 2002. Updated 2007.
  • 8
    Saraiya M,Goodman MT,Datta D,Chen VW,Wingo PA. Cancer registries and monitoring the impact of prophylactic HPV vaccines: potential role. Cancer. 2008; 113( 10 suppl): 30473057.
  • 9
    Census Quickfacts. Available at: Accessed October 24, 2007.
  • 10
    Watson M, et al. Using population-based cancer registry data to assess the burden of HPV-associated cancers in the US: Overview of methods. Cancer 2008; 113( 10 suppl): 28412854.
  • 11
    Cornelison TL,Montz FJ,Bristow RE,Chou B,Bovicelli A,Zeger SL. Decreased incidence of cervical cancer in Medicare-eligible California women. Obstet Gynecol. 2002; 100: 7986.
  • 12
    Sherman ME,Wang S,Carreon J,Devesa S. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer. 2005; 103: 12581264.
  • 13
    Henson RM,Wyatt SW,Lee NC. The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to 2 major health issues for women. J Public Health Manag Pract. 1996; 2: 3647.
  • 14
    Janerich DT,Hadjimichael O,Schwartz PE, et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health. 1995; 85: 791794.
  • 15
    Bohm S,Rafferty A,McGee H. Health risk behaviors in the state of Michigan: 2002 Behavioral Risk Factor Survey. Lansing, MI: Michigan Department of Community Health, Bureau of Epidemiology, Epidemiology Services Division; 2003.
  • 16
    Lundberg GD. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA. 1989; 262: 931934.
  • 17
    Koss LG. The new Bethesda System for reporting results of smears of the uterine cervix. J Natl Cancer Inst. 1990; 82: 988991.